Breathe Well Live Well
Can an increased cholinergic tone constitute a predictor of positive response to tiotropium in patients with moderate asthma?
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):791-3
Authors: Liccardi G, Salzillo A, Calzetta L, Ora J, Cazzola M, Matera MG, Rogliani P
PMID: 27393788 [PubMed – in process]
View full post on pubmed: asthma
OlympicTalk (blog) |
Brazil's top female swimmer tests positive for substance in asthma medication, reports say
OlympicTalk (blog) Etiene Medeiros, Brazil's most decorated female swimmer, failed a May 8 drug test for a banned substance found in asthma medication, according to Brazilian media. Medeiros, 25, is the world-record holder in the non-Olympic, short-course 50m backstroke … |
View full post on asthma – Google News
Wall Street Journal |
AstraZeneca's Severe Asthma Drug Positive in Phase III
Zacks.com These randomized, double-blind, parallel-group, placebo-controlled studies evaluated the safety and efficacy of benralizumab as an add-on therapy in the treatment of severe uncontrolled asthma with eosinophilic inflammation in patients aged 12 years … AstraZeneca's Asthma Drug Shows Positive Results AstraZeneca set to go head to head against GSK with asthma drug AstraZeneca asthma drug hits goal, to enter competitive market |
View full post on asthma – Google News
Wall Street Journal |
AstraZeneca's Asthma Drug Shows Positive Results
Wall Street Journal Bing Yao, head of respiratory medicine at AstraZeneca's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in patients with severe asthma. He said the Glaxo and Teva drugs, by contrast, act indirectly by … AstraZeneca set to go head to head against GSK with asthma drug AstraZeneca asthma drug hits goal, to enter competitive market AstraZeneca's asthma biologic hits PhIII target, but still behind rivals |
View full post on asthma – Google News
Reuters |
AstraZeneca Asthma Drug Shows Positive Results
Wall Street Journal Bing Yao, head of respiratory medicine at the company's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in severe asthma patients. He said the Glaxo and Teva drugs, by contrast, act indirectly by … AstraZeneca asthma drug hits goal, to enter competitive market AstraZeneca climbs after positive asthma treatment results AstraZeneca: Asthma drug trial results positive |
View full post on asthma – Google News
Reuters UK |
AstraZeneca: Asthma drug trial results positive
MarketWatch LONDON–AstraZeneca PLC (AZN.LN) said Tuesday its potential new medicine benralizumab showed positive results in a Phase III trial for asthma treatment. The treatment "was well tolerated and achieved the primary endpoint in two pivotal Phase III … AstraZeneca boosted by good results for biotech asthma drug Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe Asthma TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial Results |
View full post on asthma – Google News
|
Positive Data Presented on Pieris Pharmaceuticals' Inhaled Asthma Program at …
Benzinga Prior to joining Pieris Dr. Fitzgerald held senior positions at Argenta Discovery and Pulmagen Therapeutics, where she was responsible for clinical development of inhaled and oral drug candidates for both COPD and asthma. Previously, she was employed … |
View full post on asthma – Google News
|
Regeneron and Sanofi Announce Positive Pivotal Phase 2b Dupilumab Data in …
Benzinga Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today shared positive results from an interim analysis of a pivotal Phase 2b study of dupilumab in adult patients with moderate-to-severe asthma, who are uncontrolled despite treatment with … |
View full post on asthma – Google News
|
Positive results for Sanofi/Regeneron's dupilumab in asthma
The Pharma Letter French pharma major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals (Nasdaq: REGN) have released positive results from the interim analysis of a dose-ranging Phase IIb study of dupilumab in adult patients with uncontrolled … |
View full post on asthma – Google News
|
AstraZeneca Gets Positive Results for Asthma Drug
Drug Discovery & Development AstraZeneca announced that The Lancet Respiratory Medicine has published positive safety and efficacy data from a Phase 2b study evaluating benralizumab, a novel investigational monoclonal antibody, in patients with severe, uncontrolled asthma and … AstraZeneca gets some upbeat asthma data to back would-be IL-5 blockbuster AstraZeneca share price: Novel drug shows positive results for severe asthma AstraZeneca's benralizumab succeeds in severe asthma |
View full post on asthma – Google News